chenodeoxycholic acid has been researched along with Movement Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dale, RC; Mohammad, SS; Paget, SP | 1 |
| Ishikawa, A; Kondo, R; Miyatake, T; Wakamatsu, N; Yuasa, T | 1 |
1 review(s) available for chenodeoxycholic acid and Movement Disorders
| Article | Year |
|---|---|
Current therapies and therapeutic decision making for childhood-onset movement disorders.
Topics: Adrenergic alpha-Agonists; Anticonvulsants; Autoimmune Diseases of the Nervous System; Botulinum Toxins, Type A; Cannabinoids; Cell- and Tissue-Based Therapy; Chelating Agents; Chenodeoxycholic Acid; Child; Clinical Decision-Making; Deep Brain Stimulation; Diet Therapy; Dietary Supplements; Dopamine Agents; Enzyme Replacement Therapy; GABA Agents; Gastrointestinal Agents; Genetic Therapy; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Metabolism, Inborn Errors; Monoamine Oxidase Inhibitors; Movement Disorders; Neuromuscular Agents; Organophosphorus Compounds; Pterins | 2019 |
1 other study(ies) available for chenodeoxycholic acid and Movement Disorders
| Article | Year |
|---|---|
[A case of cerebrotendinous xanthomatosis with spastic paraparesis, epilepsy, and bradykinesia].
Topics: Adult; Brain Diseases; Chenodeoxycholic Acid; Epilepsy; Female; Humans; Movement Disorders; Muscular Diseases; Paraparesis, Tropical Spastic; Tendons; Xanthomatosis | 1991 |